Posts Tagged ‘lumithera’
Valeda LDS – the first and ONLY FDA-authorised treatment for dry AMD to improve vision!
A New Era in Macular Degeneration Care – Safe, Effective and Non-Invasive 🔹 Key Highlights ✅ Rigorous Clinical Trials: LightSite II and LightSite III confirmed effectiveness. ✅ FDA-Approved (November 2024): The first and only treatment using photobiomodulation (PBM) for AMD to receive FDA approval. FDA Approval Announcement ✅Proven Track Record: Over 750,000 treatments performed worldwide…
Read MoreDiscover the Latest in Dry AMD Treatment with John Rose Optometrist
Join optometrist John Rose in conversation with journalist Angela Young as they discuss the FDA-approved Valeda Light Delivery System (LDS) treatment for Dry Age-Related Macular Degeneration (AMD). Hear directly from John and Alita, one of our AMD patients, about how this innovative therapy works and their personal experience with Valeda. 🎧✨ Listen to the…
Read MoreValeda LDS, the treatment for patients suffering from Dry Age-Related Macular Degeneration
Managing Dry Macular Degeneration (AMD) Age-Related Macular Degeneration is a gradual loss of vision that progresses with age. It normally affects central vision, particularly contrast sensitivity, dark adaptation, colour vision and depth perception – changes that influence performance and experience of day-to-day tasks and hobbies such as reading, driving, watching TV, painting etc. Early stages…
Read More